News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
398 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18015)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (122)
2 (3)
3 (17)
4 (317)
5 (398)
6 (369)
7 (315)
8 (144)
9 (1)
10 (24)
11 (168)
12 (366)
13 (237)
14 (253)
15 (114)
16 (13)
17 (22)
18 (269)
19 (262)
20 (224)
21 (281)
22 (109)
23 (5)
24 (7)
25 (43)
26 (133)
27 (210)
28 (19)
29 (25)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
BioForest
WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System
WaveForm Technologies Inc. a wholly owned subsidiary of AgaMatrix Holdings LLC and developer of novel continuous glucose monitoring products, today announced it has received CE Mark (Conformité Européenne) approval for its Cascade Continuous Glucose Monitoring (CGM) system.
November 5, 2019
·
6 min read
Business
Men’s Liberty Supports National Diabetes Awareness Month by Helping Men with Diabetes and Incontinence Get Out of Absorbant Briefs and Guards
Men’s Liberty™ is sharing the top tips from their users after a diabetes diagnosis and the preferred solution to help men regain their freedom from male incontinence. According to the Center for Disease Control, about 10% of Americans have Type 2 diabetes
November 5, 2019
·
2 min read
Deals
DNA Script to Open U.S. Office in South San Francisco to Support Commercialization of the Company’s Industry-Leading Enzymatic Synthesis Technology
DNA Script today announced the acquisition of new office and lab space in South San Francisco, California.
November 5, 2019
·
3 min read
BioCapital
FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations
Today, the U.S. Food and Drug Administration authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology.
November 5, 2019
·
5 min read
Medopad Discloses Funding for Ambitious Digital Medicine Innovations
Medopad, a fast-growing healthtech AI startup headquartered in London, has earned investment in a funding round led by Leaps by Bayer in to further develop its digital health platform.
November 5, 2019
·
5 min read
Atriva Therapeutics to present at the BIO-Europe in Hamburg
Atriva Therapeutics GmbH, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, will present at the upcoming 25th Annual International Partnering Conference BIO-Europe®.
November 5, 2019
·
1 min read
Genetown
Variantyx Launches Its Whole Genome Sequencing (WGS)-Based In-Silico Panel Program at National Society of Genetic Counselors Annual Conference
Variantyx today announced the launch of its in-silico panel program which is an extension of its Genomic Unity™ whole genome sequencing (WGS)-based testing service. Available to clinicians since 2017, Genomic Unity™ has been instrumental in resolving many complex patient cases
November 5, 2019
·
1 min read
Business
Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells)
Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients
November 5, 2019
·
6 min read
FDA
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia
According to the National Institute of Health’s National Cancer Institute, in the United States, there will be an estimated 5,930 new cases of ALL and an estimated 1,500 related deaths in 2019.
November 5, 2019
·
4 min read
Pharm Country
Enzychem Lifesciences Announces Poster Presentation at Liver Meeting 2019
The Liver Meeting 2019, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 8-12 in Boston, MA.
November 5, 2019
·
2 min read
Previous
19 of 40
Next